Zimbabwe has rejected a major American health deal valued at 367 million US dollars (272 million pounds) spanning five years over the United States' request for sensitive information.
This rejection became public after a official document dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
A government representative later clarified that the United States was seeking health data for scientific study and commercial purposes but was unwilling to share the benefits from future treatments.
"We must now begin the difficult and regrettable task of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has called for more dialogue to reach a agreement agreeable to both sides so the nation's vital HIV treatment initiative can proceed.
Wider Background
Zimbabwe's decision follows a comparable case in Kenya, where a court suspended a related health funding agreement after legal challenges were filed about the safety of Kenyans' medical information.
Since returning to office last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had overseen aid for the American government, but Trump stated its spending was "wasteful" and his government was pursuing direct bilateral agreements to boost openness and responsibility.
As per statements, 16 nations in Africa have so far signed similar health pacts, representing more than $18.3bn in new funding.
Details of the Rejected Deal
The money for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "asymmetrical".
"The proposal required Zimbabwe to provide its genetic material and health information for a long time, without any corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," his statement read.
"Put simply, our country would provide the basic resources for scientific discovery without any certainty that the resulting innovations would be accessible to our population should a future pandemic emerge."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending frameworks previously established through the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework designed to manage future global health emergencies.
"This mechanism is designed to ensure that when a nation contributes its information, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.
"We welcome ongoing discussions with our American counterparts on how subsequent co-operation might be structured in a way that honours the sovereignty and interests of both nations."
Health Experts Response
Medical experts stated it understood the government's concerns, but recommended that negotiations should continue considering a large portion of the nation's HIV programmes were funded by foreign aid.
"In cases where specific concerns arise, including those involving information security or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," it added.
This impasse underscores the complex challenges between accepting much-needed foreign assistance and protecting national sovereignty in an ever more data-driven world.